nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—embryo—amyotrophic lateral sclerosis	0.07	0.15	CbGeAlD
Tiludronate—ATP6V1A—hindbrain—amyotrophic lateral sclerosis	0.067	0.144	CbGeAlD
Tiludronate—PTPN1—N-cadherin signaling events—GRIA2—amyotrophic lateral sclerosis	0.0559	0.105	CbGpPWpGaD
Tiludronate—PTPN1—N-cadherin signaling events—DCTN1—amyotrophic lateral sclerosis	0.0494	0.0923	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—RAB5A—amyotrophic lateral sclerosis	0.0429	0.0802	CbGpPWpGaD
Tiludronate—ATP6V1A—embryo—amyotrophic lateral sclerosis	0.0419	0.0901	CbGeAlD
Tiludronate—ATP6V1A—brainstem—amyotrophic lateral sclerosis	0.0384	0.0826	CbGeAlD
Tiludronate—PTPN1—nervous system—amyotrophic lateral sclerosis	0.0336	0.0722	CbGeAlD
Tiludronate—PTPN1—central nervous system—amyotrophic lateral sclerosis	0.0323	0.0695	CbGeAlD
Tiludronate—PTPN1—cerebellum—amyotrophic lateral sclerosis	0.0316	0.068	CbGeAlD
Tiludronate—PTPN1—Insulin Signaling—PTPRF—amyotrophic lateral sclerosis	0.0285	0.0533	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RAB5A—amyotrophic lateral sclerosis	0.0285	0.0533	CbGpPWpGaD
Tiludronate—ATP6V1A—medulla oblongata—amyotrophic lateral sclerosis	0.0268	0.0576	CbGeAlD
Tiludronate—PTPN1—brain—amyotrophic lateral sclerosis	0.0257	0.0552	CbGeAlD
Tiludronate—ATP6V1A—spinal cord—amyotrophic lateral sclerosis	0.0239	0.0514	CbGeAlD
Tiludronate—ATP6V1A—nervous system—amyotrophic lateral sclerosis	0.0201	0.0433	CbGeAlD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—RAB5A—amyotrophic lateral sclerosis	0.0199	0.0373	CbGpPWpGaD
Tiludronate—ATP6V1A—central nervous system—amyotrophic lateral sclerosis	0.0194	0.0417	CbGeAlD
Tiludronate—ATP6V1A—cerebellum—amyotrophic lateral sclerosis	0.0189	0.0407	CbGeAlD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—amyotrophic lateral sclerosis	0.0189	0.0353	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—IGF1—amyotrophic lateral sclerosis	0.0178	0.0333	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.0174	0.0326	CbGpPWpGaD
Tiludronate—ATP6V1A—brain—amyotrophic lateral sclerosis	0.0154	0.0331	CbGeAlD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.0136	0.0254	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.0122	0.0229	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.0101	0.0189	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.00983	0.0184	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—amyotrophic lateral sclerosis	0.00943	0.0176	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—VEGFA—amyotrophic lateral sclerosis	0.00925	0.0173	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00912	0.0171	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00875	0.0164	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00838	0.0157	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00701	0.0131	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00652	0.0122	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TPK1—amyotrophic lateral sclerosis	0.00646	0.0121	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00631	0.0118	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.00611	0.0114	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00592	0.0111	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00564	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00531	0.00993	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.0053	0.00991	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—VTA1—amyotrophic lateral sclerosis	0.00516	0.00966	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.0048	0.00897	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.0048	0.00897	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00428	0.00799	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00391	0.00732	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00361	0.00675	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PLB1—amyotrophic lateral sclerosis	0.00354	0.00662	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—VCP—amyotrophic lateral sclerosis	0.00315	0.0059	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00313	0.00584	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00305	0.0057	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00274	0.00512	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00248	0.00463	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00248	0.00463	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00236	0.00441	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00233	0.00436	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00233	0.00436	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CST3—amyotrophic lateral sclerosis	0.00226	0.00423	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00221	0.00413	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00221	0.00413	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00214	0.004	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00214	0.004	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.002	0.00373	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.0019	0.00355	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.0019	0.00355	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00188	0.00351	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00188	0.00351	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ATF1—amyotrophic lateral sclerosis	0.00187	0.0035	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.00186	0.00348	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP9—amyotrophic lateral sclerosis	0.00178	0.00333	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CASP9—amyotrophic lateral sclerosis	0.00165	0.00308	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.00153	0.00285	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.00144	0.00268	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB4—amyotrophic lateral sclerosis	0.00141	0.00263	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00129	0.00241	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00129	0.00241	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—C3—amyotrophic lateral sclerosis	0.00127	0.00237	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.00122	0.00227	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00121	0.00226	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00121	0.00226	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00115	0.00216	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00115	0.00216	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOE—amyotrophic lateral sclerosis	0.00109	0.00204	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000987	0.00184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000987	0.00184	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000928	0.00173	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000928	0.00173	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000918	0.00172	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00082	0.00153	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00082	0.00153	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000763	0.00143	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000763	0.00143	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—amyotrophic lateral sclerosis	0.000747	0.0014	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000631	0.00118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000631	0.00118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000486	0.000908	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000486	0.000908	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000459	0.000858	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000459	0.000858	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000412	0.00077	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000412	0.00077	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000311	0.000582	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000311	0.000582	CbGpPWpGaD
